OM:DVYSRBiotechs
Devyser Diagnostics (OM:DVYSR) Stock Turns Profitable On TTM EPS 0.92 Reinforcing Bullish Narratives
Devyser Diagnostics (OM:DVYSR) has reported Q2 2026 revenue of SEK60.2 million and net income of SEK1.6 million, equivalent to basic EPS of SEK0.10. The company has seen quarterly revenue range from SEK54.8 million in Q1 2025 to SEK72 million in Q4 2025, while basic EPS has moved from a loss of SEK1.24 per share in Q1 2025 to a profit of SEK0.92 per share on a trailing twelve month basis. This gives investors a clearer view of how the income statement has shifted over recent periods. Taken...